| Code | 01220 | ||||||||||
| MA number | 09/0767/10-S | ||||||||||
| Product Form: | cps end 56x40 mg (blis. PA/Al/PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | Zentiva, k.s., Czechia | ||||||||||
| Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 29.10.2010 |
| Pediatric posology: | Yes |
| PIL: |
PIL_Dereflin 20_40mg tvrdé gastrorezistentné kapsuly_05_2024.pdf
|
| SPC: |
SPC_Dereflin 20_40mg tvrdé gastrorezistentné kapsuly_05_2024.pdf
|
| Safety feature | Yes |
| Data update: | 18.05.2018 |
